Puhua Capital
Investor profile
Venture capital
Puhua Capital has backed 4 European tech companies across 4 funding rounds between 2021 and 2024, joining rounds totalling €413M. Most active in Healthtech. Data as of Nov 2026.
Deals
4
distinct rounds
Companies
4
backed
Active span
2021–2024
4 yrs
Total round €
€413M
sum of rounds joined
Deals by year
distinct rounds / yearPuhua Capital — deals by year — interactive chart.
Data table
| Puhua Capital — deals by year | |
|---|---|
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Top sectors
by dealsPuhua Capital — top sectors — interactive chart.
Data table
| Puhua Capital — top sectors | |
|---|---|
| Healthtech | 4 |
Stages
by dealsPuhua Capital — stages — interactive chart.
Data table
| Puhua Capital — stages | |
|---|---|
| Series B | 2 |
| Series C | 1 |
| Series D+ | 1 |
Countries
by dealsPuhua Capital — countries — interactive chart.
Data table
| Puhua Capital — countries | |
|---|---|
| UK | 4 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Amadeus Capital Partners2
- Ancora Finance Group1
- ARCH Venture Partners1
- BlackRock1
- Charles River Laboratories1
- Chimera Partners1
- Delin Ventures1
- Eldridge1
- Foresite Capital1
- Glenview Capital1
- Meltwind1
- Metaplanet1
- Millennium Venture Capital1
- Monashee Investment Management LLC1
- Northpond Ventures1
- Novalis LifeSciences1
- Novo Holdings1
- Octopus Ventures1
- Orlando Health1
- Resilience1
- Sands Capital Ventures1
- Segulah Medical1
- Tencent1
- Wealth Club1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quanta | UK | 1 | €205M |
| bit.bio | UK | 1 | €89M |
| Ori Biotech | UK | 1 | €88M |
| Inotec Amd | UK | 1 | €31M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Quanta | Series D+ | €205M | 2021-06 |
| bit.bio | Series B | €89M | 2021-11 |
| Ori Biotech | Series B | €88M | 2022-01 |
| Inotec Amd | Series C | €31M | 2024-12 |